History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Cycle for Survival Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment

Older Men with Prostate Cancer: To Treat or Not To Treat?

Watchful Waiting
As more American men live longer, more cases of prostate cancer will be diagnosed. For older men diagnosed with the disease in its early stages, the question becomes whether to treat the cancer aggressively or whether to wait and see if it progresses, a process known as watchful waiting. Conventional wisdom has held that treatment is not required because early stage prostate cancer grows so slowly that these men will most likely die from other causes. A new study challenges this accepted belief -- its results suggesting that older men who receive treatment for their prostate cancer live longer than those who do not.

What's New at MSKCC.ORG


New Online Search Tool Helps Scientists Explore Genes in Medical Literature

Computational biology researchers today announced a new Internet tool for the exploration of the scientific literature in medicine and biology. The freely accessible iHOP service provides fast, accurate, comprehensive, and up-to-date summary information on more than 80,000 biological molecules by automatically extracting key sentences from millions of PubMed documents when a search is requested. PubMed is a service of the US National Library of Medicine that includes more than 16 million citations from life science journals for biomedical articles.

Staff Spotlight - David Gin

Sloan-Kettering Institute chemist David Y. Gin's interest in chemical synthesis can be traced back to the time he spent working in the kitchen of his family's restaurant in rural Canada.

Oncology Nurse Receives National Honor

Jacqueline Barnes, RN, MPH, of Memorial Sloan-Kettering Cancer Center, has been recognized for outstanding patient care with a New York Times Job Market "Tribute to Nurses" award. The award recognizes nurses or nurse educators who have been nominated by their peers and/or patients for extraordinary achievements in the nursing profession and in patient care.

Research at Memorial Sloan-Kettering


Newly Approved Cancer Drug Based on 30 Years of Research

A drug developed at Memorial Sloan-Kettering Cancer Center and Columbia University has won approval from the US Food and Drug Administration. Vorinostat (Zolinza) -- also known by its chemical name suberoylanilide hydroxamic acid (SAHA) -- was approved in October for the treatment of cutaneous T cell lymphoma (CTCL), a form of non-Hodgkin's lymphoma.

When Biology Meets Structure - SKI Researchers Visualize Action of Major Repair Enzyme

A collaboration driven by Jayakrishnan Nandakumar, a fifth-year graduate student in the Tri-Institutional Training Program in Chemical Biology, and guided by Sloan-Kettering Institute researchers Christopher Lima and Stewart Shuman, has led to the exquisite visualization of RNA ligase 2 (Rnl2).

Events


Living Beyond Cancer Calendar

Our new Living Beyond Cancer section of the Web site includes a calendar with searchable listings of upcoming survivorship workshops, support groups, and events.

Fred's Team 2007 Events

Fred's Team is a dynamic group of first-time and veteran runners who raise funds for cancer research. Learn about Fred's Team's upcoming events for 2007.
Last Updated: Jan. 8, 2007
PrintEmail This Page